Hepatitis C virus acute exacerbation during chemotherapy and radiotherapy for oesophageal carcinoma

18Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: We report the first case of an hepatitis C virus positive patient presenting with a solid tumor and developing an exacerbation of his hepatitis C after chemotherapy. Case report: A 56-year-old white male, previously infected with hepatitis C virus and treated for epidermoid carcinoma of the oesophagus, developed hepatitis (alamine aminotransferase 2376 U/l and aspartate aminotransferase 2262 U/l) after chemotherapy with cisplatin and vinblastine. Methods: Polymerase chain reaction detected hepatitis C virus RNA in the serum during the acute phase, which returned to negative 14 weeks later. Discussion: Viral replication was probably increased during immunosuppression induced by chemotherapy. Enhanced cellular immune response in the recovery phase was the most likely cause of the hepatitis. Conclusions: More attention should be paid to liver function tests in patients with a previous history of hepatitis C virus infection. Polymerase chain reaction identification of hepatitis C virus RNA can be a very useful tool that permits rapid diagnosis and appropriate management of such cases. © 1994 Kluwer Academic Publishers.

Cite

CITATION STYLE

APA

De Pree, C., Giostra, E., Galetto, A., Perrin, L., & Zulian, G. B. (1994). Hepatitis C virus acute exacerbation during chemotherapy and radiotherapy for oesophageal carcinoma. Annals of Oncology, 5(9), 861–862. https://doi.org/10.1093/oxfordjournals.annonc.a059022

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free